NSE: CONCORDBIO - Concord Biotech Limited

Yield per half year: +39.63%
Dividend yield: 0.00%

Share chart Concord Biotech Limited


About Concord Biotech Limited

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas.

more details
It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

Industry Biotechnology
Sector Health Care
Валюта inr
Сайт https://www.concordbiotech.com
Цена ао 2047.8
Change price per day: 0% (2047.8)
Change price per week: -14.04% (2382.35)
Change price per month: +20.06% (1705.6)
Change price per 3 month: +31.16% (1561.25)
Change price per half year: +39.63% (1466.6)
Change price per year: +104.68% (1000.5)
Change price per 3 year: 0% (2047.8)
Change price per 5 year: 0% (2047.8)
Change price per 10 year: 0% (2047.8)
Change price per year to date: +32.43% (1546.35)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.6714

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 66.53 8
Yield Ebitda, % 77.79 8
Yield EPS, % 0 0
Total: 4.4

Head Job title Payment Year of birth
Mr. Sudhir Jairam Vaid Chairman & MD 1952 (73 years)
Mr. Ankur Vaid Joint MD, CEO & Director 1982 (43 years)
Mr. Lalit Sethi Chief Financial Officer
Mr. Prakash Lalchand Sajnani Company Secretary, Compliance Officer & Assistant VP of Finance
Mr. Devang Bhatt VP of Sales & Marketing and Head of Limbasi Plant-3
Mr. Manoj Kumar VP of Formulation Division & Head of Valthera Unit-2
Sundeep Bengani General Manager, International Business Development

Address: India, Ahmedabad, 16th Floor B-Wing - open in Google maps, open in Yandex maps
Website: https://www.concordbiotech.com